EUVIMEDEUVIMED entdecken
Crossref

Targeted Chromatographic Standardization and Pharmacological Validation of Hedyotis diffusa Willd. Extracts in In-Vivo Models of Inflammation and Hepatotoxicity

Vijayendra Kumar Pandey, Gaurav Jain

International Journal of Drug Delivery Technology · 25.04.2026 · 16 (19s)

DOI: 10.25258/ijddt.16.19s.66 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 25.04.2026. Verfasst von Vijayendra Kumar Pandey und 1 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The resurgence of plant-based medicine necessitates the scientific validation and quality standardization of traditionally used herbs. Hedyotis diffusa Willd. is widely employed in traditional systems for conditions including inflammation and liver disorders. However, comprehensive pharmacognostic monographs and systematic pharmacological validations correlating bioactivity with specific chemical markers are currently lacking. This study aimed to conduct an integrated pharmacognostic, phytochemical, and pharmacological evaluation to establish quality parameters and scientific credence for its therapeutic claims.

Methods

Authenticated aerial parts of H. diffusa were sequentially extracted using solvents of increasing polarity. The extracts were standardized utilizing High-Performance Thin-Layer Chromatography (HPTLC) for the fingerprinting and quantification of triterpenoids (ursolic and oleanolic acid), and a validated HighPerformance Liquid Chromatography (HPLC) method for quantifying gallic acid. The methanolic extract was evaluated for acute oral toxicity (OECD Guideline 423), in-vivo anti-inflammatory activity via a carrageenaninduced rat paw edema model, and hepatoprotective activity utilizing a paracetamol-induced hepatotoxicity model in Wistar rats.

Results

The methanolic extract exhibited a diverse phytochemical profile. HPTLC quantification confirmed the presence of ursolic acid (41.7 mg/g) and oleanolic acid (25.1 mg/g), while HPLC quantified gallic acid at 12.5 mg/g. The acute toxicity study revealed a high safety margin with no mortality at 2000 mg/kg. Pharmacologically, the extract exhibited significant, dose-dependent anti-inflammatory activity, achieving 45.35% inhibition of edema at 400 mg/kg. Furthermore, it demonstrated potent hepatoprotective effects by significantly reducing paracetamol-induced elevations in serum ALT, AST, ALP, and bilirubin, while markedly improving hepatic histoarchitecture.

Conclusion

These findings scientifically validate the traditional uses of H. diffusa for inflammatory and hepatobiliary conditions. The established chromatographic fingerprints and quantitative data provide a reliable foundation for the pharmacopoeial standardization of this botanical, tightly linking its in-vivo efficacy to its high content of triterpenoids and phenolics.

Zitieren

APA

Pandey, V. K., & Jain, G. (2026). Targeted Chromatographic Standardization and Pharmacological Validation of Hedyotis diffusa Willd. Extracts in In-Vivo Models of Inflammation and Hepatotoxicity. International Journal of Drug Delivery Technology, 16(19s). https://doi.org/10.25258/ijddt.16.19s.66

Vancouver

Pandey VK, Jain G. Targeted Chromatographic Standardization and Pharmacological Validation of Hedyotis diffusa Willd. Extracts in In-Vivo Models of Inflammation and Hepatotoxicity. International Journal of Drug Delivery Technology. 2026;16(19s). doi:10.25258/ijddt.16.19s.66

BibTeX
@article{Pandey2026,
  author = {Pandey, Vijayendra Kumar and Jain, Gaurav},
  title = {Targeted Chromatographic Standardization and Pharmacological Validation of Hedyotis diffusa Willd. Extracts in In-Vivo Models of Inflammation and Hepatotoxicity},
  journal = {International Journal of Drug Delivery Technology},
  year = {2026},
  volume = {16},
  number = {19s},
  doi = {10.25258/ijddt.16.19s.66}
}
Kostenlos starten →